| year | 2026Latest | 2025 | 2024 |
|---|---|---|---|
Revenue | 0 € | 0 € -100.0% | 767,4k € -2.0% |
Profit | - | - -100.0% | 112,6k € -66.8% |
Assets | - | - | - |
Liabilities | - | - | - |
Equity | - | - -100.0% | 1,1m € +10.9% |
Employees | 11 +10.0% | 10 | - |
Overall rating | B70/100 |
Financial health | 50/100 |
Credit history | 70/100 |
Legal history | 100/100 |
Business activity | 70/100 |
| Overall risk | Medium |
No risk flags | |
Possible tax debts | |
No financial data available | |
Regular report filing | |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| - | Board member | - | |||
| - | Board member | - |
HansaBioMed Life Sciences OÜ is located at Harju maakond, Tallinn, Mustamäe linnaosa, Mäealuse tn 2/1, 12618.
In 2026, HansaBioMed Life Sciences OÜ had an average of 11 employees. View tax history →
The beneficial owners of HansaBioMed Life Sciences OÜ are Antonio Chiesi and Paolo Guazzi. View ownership details →
No, HansaBioMed Life Sciences OÜ does not have an active VAT number and is not registered as a VAT payer.
In 2026, the average gross salary at HansaBioMed Life Sciences OÜ was approximately 1009,29 € per month (net ~ 774,65 €). This is an approximate calculation. View salary details →
HansaBioMed Life Sciences OÜ was founded on February 10, 2016. The company has been operating for 10 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 10 years | - | 0% | |
Registered capital | 102 516,00 € | - | 0% |
Annual financial report for 2026.
Annual financial report for 2025.
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Registered in the Estonian business register.
| Name, surname | Shares | Ownership rights | |
|---|---|---|---|
| EXOSOMICS SIENA S.P.A. | - | 100.00% |
| Name, surname | Nationality | Birth date | |
|---|---|---|---|
| Antonio Chiesi | EE | - | |
| Paolo Guazzi | EE | - |